OncClubAll Oncology NewsPipeline Report
InsightsMedical World NewsOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsThe Talk
Conference CoverageConference Listing
Giants of Cancer CarePER EventsScientific InterchangesState of the Science Summit / IPCWebinars
Partners
Oncology Live®Oncology FellowsSupplements And Featured PublicationsAll Publications
CME/CE
Interactive ToolsLearning ModulesPresentationsSponsored
Biomarker Consortium
Print SubscriptioneNewsletter
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
Spotlight -
  • 2024 nominations are open for Giants of Cancer Care®
  • In-person and virtual events just for HCPs
  • REGISTER TODAY to explore data on a novel second-generation BTK inhibitor for adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
  • Share your views with OncChats
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
    • Partners
    • CME/CE
    • Biomarker Consortium
Advertisement

The Era of Immunotherapy for Advanced Head & Neck Cancer Squamous Cell Carcinoma

home / insights / hnscc-immunotherapy
Advertisement
Biology of Head and Neck Squamous Cell Cancer (HNSCC)

EP. 1: Biology of Head and Neck Squamous Cell Cancer (HNSCC)

December 22nd 2016
Risk Stratification for HNSCC

EP. 2: Risk Stratification for HNSCC

December 22nd 2016
Multimodality Treatment for HNSCC

EP. 3: Multimodality Treatment for HNSCC

December 22nd 2016
Historic Perspective on Systemic Therapy for Advanced HNSCC

EP. 4: Historic Perspective on Systemic Therapy for Advanced HNSCC

December 22nd 2016
Historic Perspective on Recurrent HNSCC

EP. 5: Historic Perspective on Recurrent HNSCC

December 22nd 2016
Mechanisms of Immunotherapy in HNSCC

EP. 6: Mechanisms of Immunotherapy in HNSCC

December 22nd 2016
Advertisement
Immunotherapy for Virally Induced vs High-Mutation Burden HNSCC

EP. 7: Immunotherapy for Virally Induced vs High-Mutation Burden HNSCC

December 22nd 2016
The Approval of Pembrolizumab for Recurrent HNSCC

EP. 8: The Approval of Pembrolizumab for Recurrent HNSCC

December 22nd 2016
Immunotherapy for Recurrent HNSCC

EP. 9: Immunotherapy for Recurrent HNSCC

December 22nd 2016
Nivolumab: A New Standard-of-Care

EP. 10: Nivolumab: A New Standard-of-Care

December 22nd 2016
Nivolumab-Related Efficacy and Toxicity in HNSCC Patients

EP. 11: Nivolumab-Related Efficacy and Toxicity in HNSCC Patients

December 22nd 2016
Patient Selection for Nivolumab in HNSCC

EP. 12: Patient Selection for Nivolumab in HNSCC

December 22nd 2016
Advertisement
Ongoing Research of Immunotherapy in HNSCC

EP. 13: Ongoing Research of Immunotherapy in HNSCC

December 22nd 2016
Emerging PD-L1 Inhibitors for HNSCC

EP. 14: Emerging PD-L1 Inhibitors for HNSCC

December 22nd 2016

Latest Conference Coverage

Ribociclib Plus Endocrine Therapy Improves PFS and OS in Elderly Patients With HR+/HER2– Breast Cancer

Dr Ganesan on the Use of ctDNA Assays For MRD Detection in Cancer Care

Dr Habib on Developments in Palliative Care For Patients With Cancer

Dr Boland on the Emergence of KRAS G12C Inhibitors in mCRC

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777
© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact